Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Medication Interventions: H2 Blockers vs Proton Pump Inhibitors When behavioral modification isn't sufficient, pharmacological acid suppression becomes necessary
A Study Looking at How Insulin Icodec is Taken up in the Blood When Administered in Different Injection Sites in People With Type 2 Diabetes Intervention 1 Not provided Anticipated Start Date Not provided Actual Start Date 2020-10-01 Anticipated Date of Last Follow-up 2023-01-19 Estimated Primary Completion Date Not provided Estimated Completion Date Not provided Actual Primary Completion Date 2021-09-27 Actual Completion Date 2021-09-27 Age Cohort Genders Accepts pregnant individuals Unspecified Accepts lactating individuals Unspecified Accepts healthy individuals No Inclusion Criteria: * Male or female * Aged 18-69 years (both inclusive) at the time of signing informed consent * Body mass index between 18.5 and 38.0 kg/m\^2 (both inclusive) * Diagnosed with type 2 diabetes mellitus above or equal to 180 days prior to the day of screening * HbA1c (glycated haemoglobin) below or equal to 9.0 percentage at screening * Current daily basal insulin treatment of 0.2-1.0 (I)U/kg/day (both inclusive) with or without any of the following anti-diabetic drugs/regimens with stable doses above or equal to 90 days prior to the day of screening: * Any metformin formulation * Other oral antidiabetic drugs: DPP-4 inhibitors / SGLT2 inhibitors / Oral combination products (for the allowed individual oral antidiabetic drugs) * Oral or injectable GLP-1 (glucagon-like pept Not provided Interventional (clinical trial) 25 Randomized Cross-over assignment Not provided Open label Not provided Treatment NCT04582435 Phase I Completed Novo Nordisk A/S The aim of the study is to improve clinical outcomes for patients with type 2 diabetes by limiting the burden associated with insulin treatment
Dr Sonya Babu-Narayan, our Clinical Director, said: So-called weight loss drugs like semaglutide have proven benefits beyond reducing the number on the scales they are now considered important medicines for preventing deadly heart attacks and strokes
Studies have shown that GHK-Cu can stimulate collagen and glycosaminoglycan synthesis, improve skin remodeling, and support wound healing processes
Limitations The number of studies enrolled was limited, and their quality was not high
In addition to its health benefits, glutathione has been shown to have skin-whitening properties, which makes it an ideal treatment for individuals who want to achieve a brighter and more even complexion
